When Your Body Breaks While You’re Building: The Hidden Medical Trauma of Driven Women Founders

FOUNDER HEALTH • April 22, 2026

The Cry That Came From Nowhere

She is standing in her kitchen on a Tuesday morning, her son’s eighth birthday cake on the counter, the balloons tied to the dining chairs, the house full of the particular chaos of eight-year-olds. She is laughing at something her husband says, and then she is not. The tears come so fast and so completely that she has to excuse herself to the bathroom, where she sits on the edge of the tub for seven minutes, pressing a cold washcloth to her face, trying to understand what just happened.

Her son is eight. He is healthy. She is healthy. The company she spent a decade building sold eighteen months ago for a number that still doesn’t feel entirely real. She has, by every metric she ever used to measure a life, won. And yet she is sitting on the edge of her bathtub on her son’s birthday, crying so hard she can’t catch her breath, with absolutely no idea why.

Except that she does know why, somewhere below the level of language. She knows it has something to do with the fact that three months after closing the Series B that made the exit possible, she was diagnosed with stage II breast cancer. She knows it has something to do with the fact that she scheduled her chemotherapy infusions around her board meetings. She knows it has something to do with the fact that she told almost no one — not her investors, not her co-founder, not most of her team — because she had decided, in the quiet, terrifying clarity of the oncologist’s office, that the company could not afford for her to be sick.

She was right, in the narrow sense. The company survived. The exit happened. She is in remission. Her son is eight. But the body kept the score, as Bessel van der Kolk, MD, psychiatrist and trauma researcher at Boston University School of Medicine, would say. The grief she never allowed herself to feel during the chemo years is still there, waiting patiently in the body, surfacing at birthday parties and in grocery store parking lots and in the middle of perfectly ordinary Tuesday mornings.

This is founder medical trauma. It is one of the most invisible, most unacknowledged wounds in the founder ecosystem. And it is far more common than anyone talks about.

In my work with driven women founders, I encounter this pattern repeatedly. Women who navigated catastrophic health crises — cancer, autoimmune disease, cardiac events, neurological diagnoses — while simultaneously building companies, raising rounds, managing teams, and performing the relentless competence that the founder role demands. They survived both the illness and the build. They are, by any reasonable definition, extraordinary. And they are carrying an unprocessed wound that no one in their ecosystem ever gave them permission to acknowledge.

I want to give you that permission now. What you experienced was not just difficult. It was traumatic. And the fact that you kept going doesn’t mean you didn’t need to stop. It means you were running so fast that the grief couldn’t catch you. It has caught you now. And the work of tech founder burnout recovery — the real work, not the optimization work — begins with acknowledging that.

What Is Founder Medical Trauma?

Medical trauma as a clinical category is well-established. The research of Robert Scaer, MD, neurologist and trauma researcher and author of The Body Bears the Burden, documents how medical procedures, diagnoses, and hospitalizations can imprint on the nervous system in ways that are indistinguishable from other forms of trauma. The body doesn’t distinguish between a car accident and a cancer diagnosis in terms of the physiological stress response it generates. Both activate the same threat-detection systems, flood the body with the same stress hormones, and can leave the same lasting imprint on the autonomic nervous system.

What makes founder medical trauma a distinct clinical phenomenon is the compounding factor of the build itself. When you are diagnosed with a serious illness during the founding years of your company, you are not just managing a medical crisis. You are managing a medical crisis while simultaneously carrying the weight of your team’s livelihoods, your investors’ capital, your own identity, and the relentless demands of a company that does not pause for illness. The result is a profound splitting: the part of you that is sick, frightened, and in need of care is systematically suppressed so that the part of you that is the CEO, the founder, the leader can continue to function.

This suppression is not a failure of character. It is a survival strategy. But survival strategies have costs. The emotional and physiological material that gets suppressed doesn’t disappear; it goes underground. It lives in the body as chronic tension, as a hair-trigger stress response, as a pervasive sense of dread that has no identifiable source, as tears that arrive without warning at birthday parties. The somatic signs of burnout and unprocessed medical trauma overlap significantly. Both present as physical exhaustion that doesn’t respond to rest, as a body that feels simultaneously numb and hypersensitive, as a nervous system that can’t distinguish between genuine threat and ordinary stress.

But founder medical trauma has an additional layer: the specific grief of having been sick in secret, of having carried a terrifying diagnosis alone, of having made the calculation — consciously or not — that the company’s survival mattered more than your own healing. That calculation may have been necessary. It may have been the only viable option at the time. But it left a debt, and that debt is now due.

Gabor Maté, MD, Canadian physician and trauma specialist and author of When the Body Says No, has spent decades documenting the relationship between chronic stress, emotional suppression, and physical illness. His research suggests that the very qualities that make founders exceptional — the relentless drive, the capacity to override discomfort, the ability to suppress personal needs in service of a larger goal — are the same qualities that create vulnerability to serious illness. The body, he argues, cannot sustain indefinite suppression of its own signals without eventually breaking down. The illness, in this framework, is not a random event. It is the body’s final, desperate communication that something has to change.

For many of the founders I work with in therapy for post-exit founders, the medical crisis during the build years was the body’s first attempt to deliver that message. The delayed traumatic response they’re experiencing now is the second attempt. The body is remarkably patient. It will keep sending the message until someone is finally ready to receive it.

The Neurobiology of Surviving While Building

To understand why the grief of founder medical trauma surfaces so powerfully after the fact, we need to look at what was happening in your body during the build. The founder years are, neurobiologically speaking, a state of chronic sympathetic nervous system activation. You are operating in a sustained fight-or-flight response, flooded with cortisol and adrenaline, your threat-detection systems on permanent high alert. This is the biological cost of the relentless pressure, uncertainty, and responsibility of building a company from nothing.

When you add a serious medical diagnosis to this already-stressed system, something remarkable and deeply adaptive happens. The body, recognizing that it cannot afford to process the full emotional weight of the diagnosis while simultaneously managing the demands of the build, essentially compartmentalizes. The fear, the grief, the shock, the existential terror of a cancer diagnosis — all of this gets stored in the body’s implicit memory system, the same system that Bessel van der Kolk, MD, describes as encoding trauma in the viscera, in the muscles, in the nervous system itself, rather than in the narrative, verbal memory that we can consciously access and process.

This is why you can tell the story of your diagnosis with remarkable calm. You can describe the oncologist’s office, the treatment protocol, the side effects, the milestones of recovery, with the same analytical precision you would use to describe a product launch. The narrative memory is intact and coherent. But the emotional and physiological memory — the raw, unprocessed terror of lying in a chemo chair wondering if you would see your children grow up — is stored in the body, inaccessible to the verbal mind, waiting for a moment of sufficient safety to surface.

Robert Sapolsky, PhD, professor of biology and neurology at Stanford University and author of Why Zebras Don’t Get Ulcers, provides the physiological framework for understanding the long-term cost of this suppression. Unlike zebras, who experience acute stress responses and then return to baseline, humans are capable of sustaining chronic psychological stress that keeps the cortisol system activated for months and years at a time. This chronic activation suppresses immune function, disrupts hormonal regulation, and creates the conditions for exactly the kinds of illnesses — autoimmune disease, cancer, cardiovascular events — that many founders experience during the build years.

Stephen Porges, PhD, neuroscientist at the Kinsey Institute, Indiana University, and developer of the Polyvagal Theory, adds another crucial layer to this understanding. The nervous system, he argues, is constantly scanning the environment for cues of safety and threat. During the build years, the nervous system of a founder managing both a company and a serious illness is receiving a continuous flood of threat signals from both sources simultaneously. The autonomic nervous system responds by maintaining a state of chronic mobilization — the sympathetic activation that keeps you functional and performing — while simultaneously suppressing the dorsal vagal responses of rest, digestion, and healing that the body needs to recover from illness.

In other words, the very neurobiological state required to keep building your company is physiologically incompatible with the state required to heal from a serious illness. You were doing both simultaneously, which means neither was happening fully. The company survived, but the healing was deferred. The deferred healing is what you’re experiencing now, in the form of the delayed traumatic response.

The cruel irony is that the very drive that built your company may have contributed to the illness — through the chronic stress and immune suppression of the build years — and the very suppression that allowed you to keep building through the illness created the conditions for the delayed traumatic response you’re experiencing now. This is not a reason for self-blame. It is a reason for profound compassion toward yourself, and toward the impossible situation you were navigating.

How This Shows Up: Ana’s Story

Ana is in her mid-40s. She sits across from me in my office, her posture impeccable, her hands folded in her lap with the careful stillness of someone who has spent years learning to manage her physical presentation. She is two years out from her “all clear” — the oncologist’s declaration that the cancer is in remission, the word that was supposed to close the chapter. She sold her health-tech company eighteen months ago in a deal that validated everything she had built. She has, she tells me, everything she ever worked for.

She came to therapy for post-exit founders because she cried through her son’s entire eighth birthday party and couldn’t explain why. She has been crying in unexpected places for about six months now. In the car. In the shower. At her desk when she is supposed to be reviewing investment proposals for her family office. She is not sad, she tells me. She is not depressed, exactly. She just cries.

“I was diagnosed three months after we closed the Series B,” she says, her voice carefully neutral. “Stage II. My oncologist was wonderful. The treatment protocol was aggressive but it worked. I did six rounds of chemo, then surgery, then radiation. I finished treatment fourteen months later. During that entire time, I told my husband, my mother, and my best friend. That was it.”

She pauses. Outside my window, a car passes. She watches it go.

“I scheduled the infusions on Fridays so I could recover over the weekend and be functional by Monday. I wore a wig to board meetings. I didn’t tell my co-founder. I didn’t tell my investors. I didn’t tell my team.” She says this without apparent judgment, as if she is describing a logistical decision she made about office space. “The company couldn’t afford for me to be sick. So I wasn’t sick. Not officially.”

I ask her what it was like to sit in the chemo chair on those Fridays.

For the first time, something shifts in her face. The careful neutrality cracks, just slightly, around the eyes. “I used to bring my laptop,” she says. “I would work through the infusions. I had a standing call with my VP of Engineering at two o’clock every Friday. I never missed it.” She stops. “I don’t know why I’m telling you that like it’s something to be proud of.”

This is the moment I always wait for in this work. The moment when the founder’s own narrative begins to question itself. Ana has spent two years telling herself the story of how she handled her cancer diagnosis with extraordinary grace and competence. She worked through chemo. She protected her company. She won. But sitting in my office, she is beginning to feel the weight of what that story cost her — the grief she never allowed herself to feel, the fear she never allowed herself to express, the profound aloneness of sitting in a chemo chair with a laptop, performing CEO instead of allowing herself to be a woman who was terrified of dying.

“What would have happened,” I ask her gently, “if you had let yourself be scared?”

She is quiet for a long time. The clock on the wall ticks. A bird moves past the window. “I don’t know,” she finally says. “I never found out.”

Ana is experiencing the classic presentation of founder medical trauma. The curse of competency — the extraordinary capacity to function at the highest level regardless of internal state — allowed her to survive both the illness and the build. But it also prevented her from processing either experience in real time. Now that the external pressure has lifted, the unprocessed grief is surfacing. The tears at the birthday party were not random. They were the body finally creating the space to feel what it couldn’t afford to feel three years ago.

The specific trigger — her son’s birthday — is not accidental. During her treatment, one of the fears she suppressed most completely was the fear that she would not live to see her children grow up. She never let herself feel that fear fully. But her body remembered it. And when her son turned eight, healthy and loud and completely unaware of what his mother had carried, the body finally said: now. Now we feel this. Now we grieve the version of those years that could have been, if the culture had allowed for illness without professional consequence.

What I see in Ana, and in every founder navigating this terrain, is the profound cost of the arrival fallacy. She believed, at some level, that the exit and the remission would resolve everything — that reaching the destination would make the journey’s cost disappear. It doesn’t work that way. The journey’s cost has to be processed, grieved, and integrated. That is the work we are doing together.

The Four Patterns of Illness During the Build

In my clinical practice with female tech founders and driven women entrepreneurs, I have identified four distinct patterns in how serious illness manifests and is managed during the building years. Each pattern creates its own specific psychological wound, and each requires a somewhat different therapeutic approach. Most founders I work with embody elements of multiple patterns simultaneously.

Pattern A: Illness Masked by the Build — “I didn’t have time to feel it.”
This is Ana’s pattern. The illness is real, the diagnosis is serious, but the demands of the build create a context in which the emotional reality of the illness cannot be processed in real time. The founder compartmentalizes completely, functioning at a high level professionally while the body absorbs the physiological and emotional cost of both the illness and the suppression. The delayed grief response is often the most severe in this pattern, because the gap between the external narrative — I handled it brilliantly — and the internal reality — I was terrified and alone — is the widest. The therapeutic work involves closing that gap, slowly and carefully, allowing the internal reality to finally be witnessed and honored.

Pattern B: Illness Subordinated to the Build — “I scheduled chemo around board meetings.”
In this pattern, the founder acknowledges the illness but explicitly subordinates it to the company’s needs. Treatment is scheduled around business obligations. Recovery time is minimized. The founder communicates a message — to herself and to her team — that the company’s survival is more important than her own healing. This pattern often creates a specific form of moral injury: the founder later recognizes that she communicated to herself, at the deepest level, that she was less important than the business she was building. The therapeutic work involves grieving this self-abandonment and rebuilding a relationship with the self that is not predicated on performance and productivity.

Pattern C: Illness Weaponized by the Build — “I wanted to prove I could work through it.”
This pattern is perhaps the most painful to examine in retrospect. The founder uses the illness as an opportunity to prove her extraordinary resilience, her indispensability, her superhuman capacity to perform under pressure. The illness becomes another achievement, another data point in the narrative of exceptional competence. “I worked through chemo” becomes a badge of honor rather than a warning sign. The wound here is the recognition that the drive to prove herself was so powerful that she used her own suffering as a performance. The therapeutic work involves examining the underlying beliefs about worthiness and value that made this performance feel necessary — often rooted in early experiences where love and approval were conditional on achievement.

Pattern D: Illness Hidden from the Build — “I didn’t tell my team, my investors, my co-founders.”
This pattern involves the specific wound of radical secrecy. The founder carries the diagnosis entirely alone in the professional sphere, creating a profound split between her public identity and her private reality. The isolation of this secrecy is its own form of trauma. She sits in board meetings, investor calls, and team all-hands, performing health and competence while carrying a diagnosis that she is terrified will be used against her. The therapeutic work involves grieving the aloneness of that experience and examining the beliefs — about vulnerability, about what investors and co-founders would do with the information, about the gendered cost of being seen as sick in a culture that rewards invulnerability — that made the secrecy feel necessary.

Understanding which pattern or combination of patterns characterizes your own experience is the first step toward targeted healing. Each pattern requires a different clinical emphasis, though all of them ultimately lead to the same destination: the integration of the full truth of what you carried, and the rebuilding of a relationship with your body that is based on care rather than performance.

Both/And: Healed AND Haunted

Angela is in her late 30s. She developed a severe lupus flare during her founding year — the year she describes as “the year I was trying to build something real while my immune system was trying to destroy me.” She is in clinical remission now, has been for five years. She runs a successful company. She is, by any medical definition, healed.

She came to see me after finding a photograph.

She was cleaning out a storage box — the kind of box that accumulates during the chaos of a founding year, full of conference badges and pitch decks and the detritus of a life lived at maximum velocity — and she found a photograph of herself from that period. She is standing outside a conference room, smiling for the camera, her co-founder’s arm around her shoulders. She looks, to any outside observer, like a confident, energetic founder at the beginning of something exciting.

She could not put the photograph down for forty minutes.

“I know what was happening that week,” she tells me, sitting across from me the next day, the photograph in her bag. “I had just come from a rheumatology appointment where they told me my kidney function numbers were concerning. I had a joint pain flare so bad I could barely grip a pen. I was on a medication that made me nauseous from the moment I woke up until about two in the afternoon.” She pauses. “And I am smiling in that photograph like everything is fine. Because it had to be fine. We were in the middle of a seed round.”

She reaches into her bag and puts the photograph on the cushion between us. We both look at it for a moment. The woman in the photograph is smiling with her whole face. She looks like she is exactly where she wants to be.

“Who was that?” Angela asks, and her voice breaks on the last word.

Angela is experiencing the Both/And of founder medical trauma. She is healed — genuinely, medically, clinically healed. The lupus is in remission. The founding year is behind her. The company is thriving. And she is haunted. The photograph unlocked something that five years of remission and professional success had not resolved: the grief for the woman in that picture, the woman who was sick and scared and performing wellness for the camera because the alternative was unthinkable.

What I see in Angela, and in every founder navigating this terrain, is the false dichotomy that the culture imposes. You are either healed or you are sick. You are either grateful for your survival or you are ungrateful. You are either a success story or a cautionary tale. The Both/And reality — that you can be in remission and still be carrying unprocessed grief, that you can be thriving professionally and still be haunted by the woman you had to be during the illness years — has no cultural container.

Healing requires building that container. It requires saying, out loud, in a space that can hold the full complexity: I am grateful to be alive. I am proud of what I built. I am haunted by the cost of how I built it. I grieve the care I didn’t give myself. I am angry that the culture made me choose between my health and my company. All of these things are true simultaneously, and none of them cancels out the others.

The photograph Angela couldn’t put down was not just a memory. It was a message from the part of her that was never allowed to be sick, never allowed to be scared, never allowed to be anything other than a founder. That part had been waiting five years for someone to look at it directly and say: I see you. What you carried was real. You deserved more care than you gave yourself. That is the beginning of the work of identity after burnout and medical trauma — not erasing the story of what you built, but integrating the full cost of how you built it.

The Systemic Lens: Why Founder Culture Rewards Dissociation from the Body

The individual wounds of founder medical trauma do not exist in a vacuum. They are produced and sustained by a specific cultural context — the founder ecosystem — that has systematically rewarded dissociation from the body and penalized any acknowledgment of physical vulnerability. Understanding this systemic context is essential for healing, because it allows you to externalize the shame and recognize that the choices you made during your illness were not personal failures. They were rational responses to an irrational system.

The mythology of the “warrior founder” is pervasive and deeply damaging. The stories that circulate in Silicon Valley and the broader startup ecosystem celebrate founders who worked through illness, who slept on office couches, who pushed through physical collapse in service of the mission. These stories are told as evidence of exceptional commitment and extraordinary resilience. They are rarely examined for what they also reveal: a culture that has normalized the subordination of human biological needs to corporate performance metrics.

This mythology has a particularly insidious effect on women founders. The founder ecosystem already subjects women to a double standard of scrutiny and skepticism. Women founders are more likely to be questioned about their commitment, their capacity for the demands of the role, their ability to manage both the company and their personal lives. In this context, any acknowledgment of physical vulnerability — any admission of illness, any request for accommodation, any visible sign of human limitation — carries a disproportionate professional cost. The implicit message is clear: if you can’t handle the pressure, maybe you were never really cut out for this.

The result is a specific form of gendered pressure to perform invulnerability. Women founders who are sick during the build years are not just managing a medical crisis; they are managing the crisis while simultaneously managing the perception that the crisis might be used as evidence that they were never quite up to the demands of the role. This is why Ana told almost no one. This is why Angela smiled for the camera. This is why so many of the women I work with in therapy for female founders describe making the same calculation: the company cannot afford for me to be sick, so I will not be sick.

The VC culture compounds this pressure in specific ways. Investors are, by the nature of their role, evaluating the risk profile of their investments. A founder who discloses a serious illness during a fundraising round is introducing a variable that most investors are not equipped to evaluate fairly. The rational response to this reality — keeping the illness private — is entirely understandable. But it creates the conditions for the radical secrecy and isolation that characterize Pattern D of founder medical trauma, and it sends a message to the founder’s own nervous system that her health is a liability to be managed rather than a reality to be honored.

We must also acknowledge the role of the broader cultural narrative around illness and achievement. The stories we tell about illness in our culture tend to follow one of two scripts: the tragedy narrative, in which illness is defeat, or the triumph narrative, in which illness is the obstacle that made the achievement more meaningful. Neither script has room for the complex, ambiguous reality of a founder who was sick and scared and kept going not because she was a warrior but because she didn’t see another option. The absence of this third narrative — the honest narrative — is itself a form of cultural harm.

Understanding this systemic context is essential for healing. The shame that many founders carry about their illness — the sense that they should have handled it better, disclosed it more gracefully, taken better care of themselves — is not a personal failing. It is the predictable result of operating in a culture that gave them no viable alternative. Recognizing this allows you to stop directing the anger inward and begin the actual work of grieving what the system cost you.

How to Heal: Trauma-Informed Therapy for Founder Medical Trauma

Healing from founder medical trauma requires a clinical approach that is specifically calibrated to the unique intersection of medical trauma, founder identity, and the particular wounds created by the suppression and secrecy of the build years. Standard grief counseling or general talk therapy is often insufficient. The body is carrying the imprint of this experience, and the healing must reach the body. I map this healing process to the foundational framework of Judith Herman, MD, psychiatrist at Harvard Medical School and author of Trauma and Recovery, whose three-stage model — Safety, Remembrance and Mourning, and Reconnection — provides the essential roadmap.

Stage 1: Safety — Stabilizing the Nervous System and Rebuilding the Body Relationship
Before we can process the medical trauma, we must first establish that the body is safe. For many founders who experienced serious illness during the build, the nervous system is still operating as if the threat is ongoing. The body that learned to suppress its own signals during the chemo years has not received the message that the crisis is over. Our first clinical task is to help the nervous system update its threat assessment — to prove, through repeated experience, that it is now safe to rest, safe to feel, safe to be in the body without performing.

This involves somatic practices — breath regulation, grounding techniques, body-based mindfulness — that help the nervous system recognize the present-moment reality of safety. We work to expand what Dan Siegel, MD, clinical professor of psychiatry at UCLA, calls the “window of tolerance” — the range of physiological activation within which the nervous system can remain regulated. This is foundational work, and it cannot be rushed. The body that spent years in survival mode needs time and repetition to learn that it is safe to rest.

We also work in this stage to establish a relationship with the body that is not predicated on performance. Many founders with medical trauma have a deeply adversarial relationship with their bodies — the body is the thing that got sick, that slowed them down, that threatened the company. Rebuilding a relationship of care and attention toward the body is essential groundwork for the deeper processing that follows. This often involves simple practices: eating slowly, sleeping without guilt, noticing physical sensations without immediately trying to manage them. For women who have spent years overriding their body’s signals, these practices can feel profoundly countercultural.

Stage 2: Remembrance and Mourning — Processing the Medical Trauma
Once the nervous system is stabilized, we turn toward the specific memories and experiences that constitute the medical trauma. This is where EMDR (Eye Movement Desensitization and Reprocessing) becomes particularly valuable. EMDR is specifically designed to process traumatic memories that are stored in the body’s implicit memory system — the system that holds the emotional and physiological charge of the experience, separate from the narrative memory that can be consciously accessed and recounted.

For Ana, this meant targeting specific memories: the moment she received the diagnosis, the first chemo infusion, the board meeting she attended while nauseous from treatment, the specific Friday afternoons when she sat in the infusion chair with her laptop, performing competence while her body was being flooded with chemotherapy. Each of these memories carried a physiological charge that the narrative mind had never fully processed. EMDR allowed us to process that charge without requiring Ana to re-traumatize herself by reliving the experiences in full verbal detail.

We also use Internal Family Systems (IFS) therapy, developed by Richard Schwartz, PhD, to work with the specific parts of the self that were created during the illness years. The part that decided the company couldn’t afford for her to be sick. The part that scheduled chemo around board meetings. The part that smiled for the camera when she was terrified. These are protector parts — parts of the self that made genuinely adaptive decisions in a genuinely impossible situation — and they deserve to be understood and honored, not shamed. But they also need to be updated: the crisis is over, and they no longer need to suppress the grief and fear they were protecting against.

The mourning work in this stage is profound and necessary. We grieve the care that wasn’t given. We grieve the aloneness of the illness years. We grieve the relationship with the body that was sacrificed to the build. We grieve the version of the founder journey that might have been possible if the culture had allowed for illness without professional consequence. This grief is real and it is necessary, and it cannot be bypassed on the way to reconnection.

Stage 3: Reconnection — Rebuilding the Relationship with the Body and the Future
The final stage of healing is about rebuilding. This means, first and foremost, rebuilding a relationship with the body that is based on care rather than performance. Many founders who have experienced medical trauma during the build years have a deeply instrumental relationship with their bodies — the body is a tool for achieving goals, and when the tool breaks down, it is a problem to be managed. Reconnection requires learning to relate to the body as a partner rather than an instrument.

This is somatic work in the deepest sense. We use body-based practices — yoga, movement, breath work, somatic experiencing as developed by Peter Levine, PhD — not as wellness activities but as therapeutic tools for rebuilding the founder’s capacity to inhabit her own body with care and attention. We work to develop what Levine calls “body literacy” — the ability to read and respond to the body’s signals rather than overriding them.

We also work in this stage on the construction of a new identity that has room for the full complexity of who you are — including the woman who was sick, who was scared, who kept going when she probably should have stopped, and who deserves, finally, to be cared for. The trauma-informed executive coaching that often follows this therapeutic work helps you build a professional future that is grounded in this more integrated identity — one that honors both your extraordinary capacity for achievement and your equally extraordinary need for care.

You built something remarkable. You survived something terrifying. You did both at the same time, which is a feat of human endurance that deserves to be honored, not minimized. But honoring it means telling the full truth of it — not just the triumph narrative, but the cost narrative. The grief narrative. The aloneness narrative. The “I was scared and I kept going and nobody knew” narrative. That story deserves to be heard. And in the hearing of it, in the full witnessing of what you carried, the haunting begins, slowly and irreversibly, to lift.

Related Reading

• Maté, Gabor. When the Body Says No: Exploring the Stress-Disease Connection. Hoboken: Wiley, 2003.
• van der Kolk, Bessel. The Body Keeps the Score: Brain, Mind, and Body in the Healing of Trauma. New York: Viking, 2014.
• Sapolsky, Robert M. Why Zebras Don’t Get Ulcers. New York: Holt, 2004.
• Levine, Peter A. In an Unspoken Voice: How the Body Releases Trauma and Restores Goodness. Berkeley: North Atlantic Books, 2010.
• Porges, Stephen W. The Pocket Guide to the Polyvagal Theory. New York: Norton, 2017.
• Colonna, Jerry. Reboot: Leadership and the Art of Growing Up. New York: Harper Business, 2019.

Medical Disclaimer

Medical Disclaimer